495
edits
Changes
ACMG technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders (2013) (view source)
Revision as of 15:32, 27 July 2016
, 15:32, 27 July 2016no edit summary
== References ==
== References ==
1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn, International Agency for Research on Cancer: Lyon, France, 2008.
<br>
<br>
2. Astbury C. Clinical Cytogenetics in Clinics in Laboratory Medicine, vol. 31(4). Elsevier Saunders: Philadelphia, PA, 2011.
<br>
<br>
3. Byrd JC, Mrózek K, Dodge RK, et al.; Cancer and Leukemia Group B (CALGB 8461). Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002;100:4325–4336.
<br>
<br>
4. Döhner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910–1916.
<br>
<br>
5. Heim S, Mitelman F. Cancer Cytogenetics, Chromosomal and Molecular Genetic Aberrations of Tumor Cells, 3rd edn. Wiley: Hoboken, New Jersey, 2009.
<br>
<br>
6. Moorman AV, Harrison CJ, Buck GA, et al.; Adult Leukaemia Working Party, Medical Research Council/National Cancer Research Institute. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 2007;109:3189–3197.
<br>
<br>
7. Mrózek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev 2004;18:115–136.
<br>
<br>
8. Armengol G, Canellas A, Alvarez Y, et al. Genetic changes including gene copy number alterations and their relation to prognosis in childhood acute myeloid leukemia. Leuk Lymphoma 2010;51:114–124.
<br>
<br>
9. Gunnarsson R, Staaf J, Jansson M, et al. Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia–a comparative study of four differently designed, high resolution microarray platforms. Genes Chromosomes Cancer 2008;47:697–711.
<br>
<br>
10. Okamoto R, Ogawa S, Nowak D, et al. Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia. Haematologica 2010;95:1481–1488.
<br>
<br>
11. Slovak ML, Bedell V, Hsu YH, et al. Genomic alterations in Hodgkin and Reed/Sternberg (HRS) cells at disease onset reveals distinct signatures for chemo-sensitive and primary refractory Hodgkin lymphoma. Clin Cancer Res 2011;17:3443–3454.
<br>
<br>
12. Walter MJ, Payton JE, Ries RE, et al. Acquired copy number alterations in adult acute myeloid leukemia genomes. Proc Natl Acad Sci USA 2009;106:12950–12955.
<br>
<br>
13. Yu L, Slovak ML, Mannoor K, et al. Microarray detection of multiple recurring submicroscopic chromosomal aberrations in pediatric T-cell acute lymphoblastic leukemia. Leukemia 2011;25:1042–1046.
<br>
<br>
14. Bungaro S, Dell’Orto MC, Zangrando A, et al. Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks. Genes Chromosomes Cancer 2009;48:22–38.
<br>
<br>
15. Carrasco DR, Tonon G, Huang Y, et al. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 2006;9:313–325.
<br>
<br>
16. Gunn SR, Mohammed MS, Gorre ME, et al. Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia. J Mol Diagn 2008;10:442–451.
<br>
<br>
17. Hagenkord JM, Gatalica Z, Jonasch E, Monzon FA. Clinical genomics of renal epithelial tumors. Cancer Genet 2011;204:285–297.
<br>
<br>
18. Paulsson K, Forestier E, Lilljebjörn H, et al. Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2010;107:21719–21724.
<br>
<br>
19. Rücker FG, Bullinger L, Schwaenen C, et al. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. J Clin Oncol 2006;24:3887–3894.
<br>
<br>
20. Usvasalo A, Elonen E, Saarinen-Pihkala UM, et al. Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization data. Leuk Res 2010;34:1476–1482.
<br>
<br>
21. Gorletta TA, Gasparini P, D’Elios MM, Trubia M, Pelicci PG, Di Fiore PP. Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotype. Genes Chromosomes Cancer 2005;44:334–337.
<br>
<br>
22. O’Keefe C, McDevitt MA, Maciejewski JP. Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies. Blood 2010;115:2731–2739.
<br>
<br>
23. Kawamata N, Ogawa S, Zimmermann M, et al. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood 2008;111:776–784.
<br>
<br>
24. Hagenkord JM, Monzon FA, Kash SF, Lilleberg S, Xie Q, Kant JA. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays. J Mol Diagn 2010;12:184–196.
<br>
<br>
25. Kallioniemi A. CGH microarrays and cancer. Curr Opin Biotechnol 2008;19:36–40.
<br>
<br>
26. Maciejewski JP, Tiu RV, O’Keefe C. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies. Br J Haematol 2009;146:479–488.
<br>
<br>
27. Watson SK, deLeeuw RJ, Horsman DE, Squire JA, Lam WL. Cytogenetically balanced translocations are associated with focal copy number alterations. Hum Genet 2007;120:795–805.
<br>
<br>
28. Kearney HM, South ST, Wolff DJ, Lamb A, Hamosh A, Rao KW; Working Group of the American College of Medical Genetics. American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities. Genet Med 2011;13:676–679.
<br>
<br>
29. Nowak NJ, Miecznikowski J, Moore SR, et al. Challenges in array CGH for the analysis of cancer samples. Genet Med 2007;9(9):585–595.
<br>
<br>
30. Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST; Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 2011;13:680–685.